Skadden advised Banner Life Sciences, while Goodwin Procter advised Cycle Pharma on the deal. Cycle Pharmaceuticals, Inc. (Cycle) announced the completion of the acquisition of Banner...
You must be a Standard 1 Year member to access this content.
Skadden advised V2X, Inc. on the offering. V2X, Inc. (“V2X”) announced the pricing of the previously announced underwritten public offering by a certain selling stockholder at...
You must be a Standard 1 Year member to access this content.
Skadden represented V2X, Inc. in the offering. V2X, Inc. announced the closing of its secondary offering of 2,000,000 million shares of common stock by a certain...
You must be a Standard 1 Year member to access this content.
